Innovator
IBD Breakout Opportunities ETF is a US-based exchange-traded fund that
seeks to provide exposure to companies that are experiencing a period
of positive momentum and potential price appreciation. The ETF tracks
the IBD Breakout Stocks Index, which is comprised of companies with a
market capitalization of at least $1 billion that are exhibiting
strong price momentum as identified by Investor's Business Daily's
proprietary system.
The ETF's portfolio is relatively
concentrated, with approximately 50 holdings. Its top holdings are in
the technology and healthcare sectors, which together make up more
than half of the portfolio. The ETF's expense ratio is 0.80%, which is
higher than the average expense ratio for ETFs.
Investors
interested in BOUT should keep in mind that the fund's concentration
in certain sectors may lead to higher volatility and risk.
Additionally, since the ETF uses a momentum-based strategy, it may not
perform as well during market downturns or periods of lower
volatility.
Overall, Innovator IBD Breakout Opportunities ETF
may be suitable for investors looking for exposure to companies with
strong price momentum and potential for further price appreciation,
but they should be aware of the higher expense ratio and concentration
risks associated with the fund.
Innovator
IBD Breakout Opportunities ETF is a US-based exchange-traded fund that
seeks to provide exposure to companies that are experiencing a period
of positive momentum and potential price appreciation. The ETF tracks
the IBD Breakout Stocks Index, which is comprised of companies with a
market capitalization of at least $1 billion that are exhibiting
strong price momentum as identified by Investor's Business Daily's
proprietary system.